T
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Price:
9.54
CNY
7.19%
Market Closed
Market Cap:
¥18.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
CN |
|
N
|
Namchow Food Group Shanghai Co Ltd
SSE:605339
|
CN |
|
T
|
Taekyung Chemical Co Ltd
KRX:006890
|
KR |
|
S
|
Shandong Xinchao Energy Corp Ltd
SSE:600777
|
CN |
|
A
|
Advani Hotels and Resorts (India) Ltd
NSE:ADVANIHOTR
|
IN |
|
Zynex Inc
NASDAQ:ZYXI
|
US |
|
Enapter AG
F:H2O
|
DE |
|
Z
|
Zhongguancun Science-Tech Leasing Co Ltd
HKEX:1601
|
CN |
|
Foran Energy Group Co Ltd
SZSE:002911
|
CN |
|
S
|
Shenzhen Success Electronics Co Ltd
SZSE:002289
|
CN |
|
P
|
Pixelworks Inc
XBER:PXLX
|
US |
|
Yantai China Pet Foods Co Ltd
SZSE:002891
|
CN |
|
Eastern Communications Co Ltd
SSE:600776
|
CN |
|
Kelsian Group Ltd
ASX:KLS
|
AU |
Multiples-Based Value
The Multiples-Based Value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 9.54 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tonghua Dongbao Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
18.7B CNY | 6.8 | 15.2 | 53.1 | 53.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 30 | 16.6 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.4 | 13.3 | 17 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
